232 related articles for article (PubMed ID: 18398511)
21. A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.
Alejo A; Saraiva M; Ruiz-Argüello MB; Viejo-Borbolla A; de Marco MF; Salguero FJ; Alcami A
PLoS One; 2009; 4(4):e5175. PubMed ID: 19365546
[TBL] [Abstract][Full Text] [Related]
22. Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model.
Kumar A; Suryadevara NC; Wolf KJ; Wilson JT; Di Paolo RJ; Brien JD; Joyce S
Sci Rep; 2020 Aug; 10(1):13167. PubMed ID: 32759969
[TBL] [Abstract][Full Text] [Related]
23. Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection.
Sakala IG; Chaudhri G; Buller RM; Nuara AA; Bai H; Chen N; Karupiah G
J Virol; 2007 Apr; 81(7):3346-53. PubMed ID: 17229697
[TBL] [Abstract][Full Text] [Related]
24. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
[TBL] [Abstract][Full Text] [Related]
25. Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection.
Rottembourg D; Filippi CM; Bresson D; Ehrhardt K; Estes EA; Oldham JE; von Herrath MG
J Immunol; 2010 Jun; 184(12):7100-7. PubMed ID: 20483769
[TBL] [Abstract][Full Text] [Related]
26. Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA).
Abdalrhman I; Gurt I; Katz E
Vaccine; 2006 May; 24(19):4152-60. PubMed ID: 16603280
[TBL] [Abstract][Full Text] [Related]
27. Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.
Lustig S; Maik-Rachline G; Paran N; Melamed S; Israely T; Erez N; Orr N; Reuveny S; Ordentlich A; Laub O; Shafferman A; Velan B
Vaccine; 2009 Mar; 27(11):1691-9. PubMed ID: 19195492
[TBL] [Abstract][Full Text] [Related]
28. Interferon function is not required for recovery from a secondary poxvirus infection.
Panchanathan V; Chaudhri G; Karupiah G
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12921-6. PubMed ID: 16123129
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old mice.
Franchini M; Hefti H; Vollstedt S; Glanzmann B; Riesen M; Ackermann M; Chaplin P; Shortman K; Suter M
J Immunol; 2004 May; 172(10):6304-12. PubMed ID: 15128820
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.
Liu L; Chavan R; Feinberg MB
BMC Immunol; 2008 Apr; 9():15. PubMed ID: 18412969
[TBL] [Abstract][Full Text] [Related]
31. Endosomal Toll-Like Receptors 7 and 9 Cooperate in Detection of Murine Gammaherpesvirus 68 Infection.
Bussey KA; Murthy S; Reimer E; Chan B; Hatesuer B; Schughart K; Glaunsinger B; Adler H; Brinkmann MM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429335
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection.
Sacramento L; Trevelin SC; Nascimento MS; Lima-Jùnior DS; Costa DL; Almeida RP; Cunha FQ; Silva JS; Carregaro V
Infect Immun; 2015 Dec; 83(12):4604-16. PubMed ID: 26371124
[TBL] [Abstract][Full Text] [Related]
33. The
Szulc-Dąbrowska L; Struzik J; Cymerys J; Winnicka A; Nowak Z; Toka FN; Gieryńska M
Front Microbiol; 2017; 8():2539. PubMed ID: 29312229
[TBL] [Abstract][Full Text] [Related]
34. [Aerosol vaccination against mousepox (infectious ectromelia) in comparison with other vaccination methods using vaccinia and mousepox vaccines].
Munz E; Reimann M; Zschekel WD
Zentralbl Veterinarmed B; 1976 Jun; 23(5-6):431-46. PubMed ID: 183420
[No Abstract] [Full Text] [Related]
35. [Vaccination against mouse pox].
Mahnel H
Tierarztl Prax; 1985; 13(3):403-7. PubMed ID: 3000022
[TBL] [Abstract][Full Text] [Related]
36. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines.
Tscharke DC; Karupiah G; Zhou J; Palmore T; Irvine KR; Haeryfar SM; Williams S; Sidney J; Sette A; Bennink JR; Yewdell JW
J Exp Med; 2005 Jan; 201(1):95-104. PubMed ID: 15623576
[TBL] [Abstract][Full Text] [Related]
37. Ectromelia virus suppresses expression of cathepsins and cystatins in conventional dendritic cells to efficiently execute the replication process.
Bossowska-Nowicka M; Mielcarska MB; Romaniewicz M; Kaczmarek MM; Gregorczyk-Zboroch KP; Struzik J; Grodzik M; Gieryńska MM; Toka FN; Szulc-Dąbrowska L
BMC Microbiol; 2019 May; 19(1):92. PubMed ID: 31077130
[TBL] [Abstract][Full Text] [Related]
38. Batf3-Dependent Dendritic Cells Promote Optimal CD8 T Cell Responses against Respiratory Poxvirus Infection.
Desai P; Tahiliani V; Abboud G; Stanfield J; Salek-Ardakani S
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875235
[TBL] [Abstract][Full Text] [Related]
39. Ectromelia virus: the causative agent of mousepox.
Esteban DJ; Buller RML
J Gen Virol; 2005 Oct; 86(Pt 10):2645-2659. PubMed ID: 16186218
[TBL] [Abstract][Full Text] [Related]
40. Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses.
Holechek SA; Denzler KL; Heck MC; Schriewer J; Buller RM; Legrand FA; Verardi PH; Jones LA; Yilma T; Jacobs BL
PLoS One; 2013; 8(10):e77879. PubMed ID: 24147092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
